Skip to main content
. 2014 Oct 16;9(10):e109418. doi: 10.1371/journal.pone.0109418

Figure 1. Vitreous levels of Cyr61 in PDR and non-diabetic patients were determined by ELISA.

Figure 1

A) Vitreous concentration of Cyr61 in patients with PDR was higher than with non-diabetic disease. The difference was significant. B) Vitreous concentration of Cyr61 in patients with active PDR was significantly higher than with quiescent PDR. Vitreous concentration of Cyr61 in patients with quiescent PDR was higher than with non-diabetic disease. The difference was significant. Results shown are the mean ± SD of three independent experiments. * P<0.05; ** P<0.01.